Arimidex

10

Transcript of Arimidex

Page 1: Arimidex
Page 2: Arimidex
Page 3: Arimidex
Page 4: Arimidex
Page 5: Arimidex
Page 6: Arimidex
Page 7: Arimidex
Page 8: Arimidex
Page 9: Arimidex
Page 10: Arimidex

Adjuvant Breast Cancer Treatment: Evolution or Revolution?...sistent with the ATAC (Arimidex, Tamoxifen, Alone or in Combination) study. AIs represent an evolution from tamoxifen,

Adjuvant Breast Cancer Treatment: Evolution or Revolution?...sistent with the ATAC (Arimidex, Tamoxifen, Alone or in Combination) study. AIs represent an evolution from tamoxifen,

Arimidex 1 mg Comprimidos recubiertos - Sitio Web del ... · 1 XXXXXAA 653 CAMCAR 1 2221 896 00 21 1 PMS Black U Technical Info Page 1 PharmaCode 2 Arimidex 1 mg Comprimidos recubiertos

Arimidex 1 mg Comprimidos recubiertos - Sitio Web del ... · 1 XXXXXAA 653 CAMCAR 1 2221 896 00 21 1 PMS Black U Technical Info Page 1 PharmaCode 2 Arimidex 1 mg Comprimidos recubiertos

Arimidex - Article 30 referral - Annex III - European Medicines Agency

Arimidex - Article 30 referral - Annex III - European Medicines Agency

OFFICE OF CLINICAL PHARMACOLOGY REVIEW · 2.2 GENERAL CLINICAL PHARMACOLOGY What is known about the general pharmacology of anastrozole? Refer to original NDA 20-541 for Arimidex.

OFFICE OF CLINICAL PHARMACOLOGY REVIEW · 2.2 GENERAL CLINICAL PHARMACOLOGY What is known about the general pharmacology of anastrozole? Refer to original NDA 20-541 for Arimidex.

hypertension, depression, nausea and vomiting, rash, … · 5.2 Bone Effects . Results from the ATAC trial bone substudy at 12 and 24 months demonstrated that patients receiving ARIMIDEX

hypertension, depression, nausea and vomiting, rash, … · 5.2 Bone Effects . Results from the ATAC trial bone substudy at 12 and 24 months demonstrated that patients receiving ARIMIDEX

NDA N 000 September 4, 2007 September 5, 2007 March 5, 2008 · Clinical Review {Dragos Roman} {22-214/N 000} {Arimidex (anastrozole)} 7.1.2 Other Serious Adverse Events ...

NDA N 000 September 4, 2007 September 5, 2007 March 5, 2008 · Clinical Review {Dragos Roman} {22-214/N 000} {Arimidex (anastrozole)} 7.1.2 Other Serious Adverse Events ...

AstraZeneca€¦ · AstraZeneca 03 Chart Medicinal Portfolio Alvesco® (ciclesonide) - Treatment to control persistent asthma in adults and adolescents. Arimidex® (anastrozole) -

AstraZeneca€¦ · AstraZeneca 03 Chart Medicinal Portfolio Alvesco® (ciclesonide) - Treatment to control persistent asthma in adults and adolescents. Arimidex® (anastrozole) -

Anastrozole 1 mg Film-coated Tablets PL 18727/0014 · version of Arimidex 1 mg Film-coated Tablets ... Anastrozole is a white to off-white crystalline ... Anastrozole 1 mg Film-coated

Anastrozole 1 mg Film-coated Tablets PL 18727/0014 · version of Arimidex 1 mg Film-coated Tablets ... Anastrozole is a white to off-white crystalline ... Anastrozole 1 mg Film-coated

Description of Commitment Study Notes US P ostmark … Arimidex Although not required to obtain pediatric exclusivity, we request that you make a commitment to monitor annually the

Description of Commitment Study Notes US P ostmark … Arimidex Although not required to obtain pediatric exclusivity, we request that you make a commitment to monitor annually the

Gene Expression Profiling for Guiding Adjuvant Chemotherapy Decisions in … · 2016. 3. 30. · Gene Expression Profiling – OHTAS 2010;10(23) Page 6 Abbreviations ATAC Arimidex,

Gene Expression Profiling for Guiding Adjuvant Chemotherapy Decisions in … · 2016. 3. 30. · Gene Expression Profiling – OHTAS 2010;10(23) Page 6 Abbreviations ATAC Arimidex,

Extended Hormonal Therapy - Provincial Health Services ...learn.phsa.ca/bcca/fpon/07HormonalTherapiesLohrisch.pdf · ANASTROZOLE (ARIMIDEX) LETROZOLE (FEMARA) EXEMESTANE (AROMASIN)

Extended Hormonal Therapy - Provincial Health Services ...learn.phsa.ca/bcca/fpon/07HormonalTherapiesLohrisch.pdf · ANASTROZOLE (ARIMIDEX) LETROZOLE (FEMARA) EXEMESTANE (AROMASIN)

ARIMIDEX® - Food and Drug Administration · NDA 20-541/S-016 Page 4 09-15-05 ARIMIDEX® Anastrozole TABLETS DESCRIPTION ARIMIDEX® (anastrozole) tablets for oral administration contain

ARIMIDEX® - Food and Drug Administration · NDA 20-541/S-016 Page 4 09-15-05 ARIMIDEX® Anastrozole TABLETS DESCRIPTION ARIMIDEX® (anastrozole) tablets for oral administration contain

PRODUCT MONOGRAPH - astrazeneca.ca · COPYRIGHT 2000, 2007, 2008 ASTRAZENECA CANADA INC. Page 5of61 ARIMIDEX has not been investigated in patients with severe hepatic impairment.

PRODUCT MONOGRAPH - astrazeneca.ca · COPYRIGHT 2000, 2007, 2008 ASTRAZENECA CANADA INC. Page 5of61 ARIMIDEX has not been investigated in patients with severe hepatic impairment.

Trial Comparison: ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) and Breast International Group (BIG) 1-98.

Trial Comparison: ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) and Breast International Group (BIG) 1-98.

Arimidex (anastrozole) tablet label

Arimidex (anastrozole) tablet label

Antineoplastic Review th, 2007 Heritage Center Rooms A and ... · 173088025 3 52 $332.82 thioguanine tabloid 40 mg tb 310020130 177 5310 $48,875.90 arimidex 1 mg tablet 78024915 65

Antineoplastic Review th, 2007 Heritage Center Rooms A and ... · 173088025 3 52 $332.82 thioguanine tabloid 40 mg tb 310020130 177 5310 $48,875.90 arimidex 1 mg tablet 78024915 65

TABLETS - HemOnc.orgFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Adjuvant Treatment ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive

TABLETS - HemOnc.orgFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Adjuvant Treatment ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive

Common CMS-HCC Diagnosis Codes* · 75 y/o patient s/p mastectomy two years ago for T2N0 breast cancer on Arimidex. It is appropriate to code Malignant neoplasm of unspecified site

Common CMS-HCC Diagnosis Codes* · 75 y/o patient s/p mastectomy two years ago for T2N0 breast cancer on Arimidex. It is appropriate to code Malignant neoplasm of unspecified site

Secondary Osteoporosis - ESIM 2013 · Drug-induced osteoporosis Glucocorticoids Aromatase inhibitors (Arimidex®, Femara®) GnRH agonists (Zoladex®) Cyclosporine A Thiazolidinediones

Secondary Osteoporosis - ESIM 2013 · Drug-induced osteoporosis Glucocorticoids Aromatase inhibitors (Arimidex®, Femara®) GnRH agonists (Zoladex®) Cyclosporine A Thiazolidinediones

‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) trial: Completed Treatment Analysis

‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) trial: Completed Treatment Analysis